Results 11 to 20 of about 108,225 (340)
Endocrine Regulations, 2019 Abstract Pheochromocytomas are rare tumors originating in the adrenal medulla. They may be sporadic or in the context of a hereditary syndrome. A considerable number of pheochromocytomas carry germline or somatic gene mutations, which are inherited in the autosomal dominant way. All patients should undergo genetic testing.
Farrugia Frederick-Anthony +1 more
openaire +4 more sources
Pheochromocytoma and heart rate variability: a systematic review and meta-analysis [PDF]
International Journal of Cardiology. Cardiovascular Risk and PreventionIntroduction: Pheochromocytoma is a catecholamine-producing tumor, that may alter cardiovascular activity. Conveniently, sympathovagal activity can be measured non-intrusively and pain-free through heart rate variability (HRV).
Frédéric Dutheil +9 more
doaj +2 more sources
The American Journal of Surgery, 1962 Since pheochromocytomas result in a curable form of hypertension, there should be an awareness of its diagnostic features. These include the following: paroxysmal hypertension, paroxysmal vasomotor phenomena, hypermetabolism with loss of weight or elevation of the basal metabolic rate, and “diabetes” with hyperglycemia and glycosuria.
V, VERTES, J, ANGELES, Y, KANTER
+7 more sources
Frontiers in Endocrinology, 2022 BackgroundMultiple endocrine neoplasia type 2A (MEN2A) is a rare syndrome that presents as medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism.
Yaohan Li +5 more
doaj +1 more source
Personalized Management of Pheochromocytoma and Paraganglioma
Endocrine reviews, 2021 Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape that allows their assignment to clusters based on underlying genetic alterations.
S. Nölting +8 more
semanticscholar +1 more source
New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical Implications
Cancers, 2022 Simple Summary Pheochromocytoma and paraganglioma (together PPGL) are rare neuroendocrine tumors that arise from chromaffin tissue and produce catecholamines.
S. Jhawar +9 more
semanticscholar +1 more source
Anesthesiology, 1978 Pheochromocytoma, a relatively rare (<0.05% of hypertensives), catecholamine‐secreting tumor, is almost always lethal unless recognized and appropriately treated. Clinical and biochemical manifestations are mainly caused by excess circulating catecholamines and hypertension.
and William M. Manger Md, Ray W. Gifford
openaire +3 more sources
Targeting heat shock protein 90 for the treatment of malignant pheochromocytoma. [PDF]
PLoS ONE, 2013 Metastatic pheochromocytoma represents one of the major clinical challenges in the field of neuroendocrine oncology. Recent molecular characterization of pheochromocytoma suggests new treatment options with targeted therapies.
Alessio Giubellino +9 more
doaj +1 more source
IJU Case Reports, 2022 Introduction Patients with multiple endocrine neoplasia type 2A (MEN2A) harboring a pathological variant in the RET gene are characterized by medullary thyroid carcinoma (MTC), pheochromocytoma, and hyperparathyroidism.
Koshiro Nishimoto +11 more
doaj +1 more source
Imaging of Pheochromocytoma and Paraganglioma
Journal of Nuclear Medicine, 2021 Imaging plays a critical role in the management of pheochromocytomas and paragangliomas and often guides treatment. The discovery of susceptibility genes associated with these tumors has led to better understanding of clinical and imaging phenotypes ...
J. Carrasquillo +6 more
semanticscholar +1 more source